Global Remdesivir (COVID-19) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Remdesivir (COVID-19) Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Remdesivir (COVID-19) report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Remdesivir (COVID-19) market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Remdesivir (COVID-19) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Remdesivir (COVID-19) key manufacturers include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group and Inovio Pharmaceuticals, etc. Gilead Sciences, Bright Gene, Hainan Haiyao are top 3 players and held % sales share in total in 2022.
Remdesivir (COVID-19) can be divided into 5mg, 10mg, 50mg and 100mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Remdesivir (COVID-19) is widely used in various fields, such as Hospital, Clinics, Drug Store and Others, etc. Hospital provides greatest supports to the Remdesivir (COVID-19) industry development. In 2022, global % sales of Remdesivir (COVID-19) went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remdesivir (COVID-19) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
Segment by Type
5mg
10mg
50mg
100mg
Hospital
Clinics
Drug Store
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remdesivir (COVID-19) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remdesivir (COVID-19), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remdesivir (COVID-19) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Remdesivir (COVID-19) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remdesivir (COVID-19) introduction, etc. Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Remdesivir (COVID-19) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Remdesivir (COVID-19) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Remdesivir (COVID-19) key manufacturers include Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group and Inovio Pharmaceuticals, etc. Gilead Sciences, Bright Gene, Hainan Haiyao are top 3 players and held % sales share in total in 2022.
Remdesivir (COVID-19) can be divided into 5mg, 10mg, 50mg and 100mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Remdesivir (COVID-19) is widely used in various fields, such as Hospital, Clinics, Drug Store and Others, etc. Hospital provides greatest supports to the Remdesivir (COVID-19) industry development. In 2022, global % sales of Remdesivir (COVID-19) went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Remdesivir (COVID-19) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
Segment by Type
5mg
10mg
50mg
100mg
Segment by Application
Hospital
Clinics
Drug Store
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Remdesivir (COVID-19) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Remdesivir (COVID-19), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Remdesivir (COVID-19) industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Remdesivir (COVID-19) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Remdesivir (COVID-19) introduction, etc. Remdesivir (COVID-19) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Remdesivir (COVID-19) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices